A β-turn rich oats peptide as an antigen in an ELISA method for the screening of coeliac disease in a paediatric population

European Journal of Clinical Investigation

Volumn 30, Issue 8, 2000, Pages 702-708

  Ribes Koninckx, C ^a   Alfonso, P ^b   Ortigosa, L ^c   Escobar, H ^d   Suarez L ^d   Arranz, E ^e   Mendez E ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

turn; AGA; Coeliac disease screening; EmA; Oats peptide

Indexed keywords

ANTIGEN; GLIADIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PEROXIDASE; SYNTHETIC PEPTIDE;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; OAT; PEDIATRICS; PRIORITY JOURNAL; STANDARDIZATION;

ADOLESCENT; ADULT; ANTIBODIES; AVENA SATIVA; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; PEPTIDES; PLANT PROTEINS; PREDICTIVE VALUE OF TESTS; PROTEIN STRUCTURE, SECONDARY; SENSITIVITY AND SPECIFICITY;

EID: 0033865901     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00684.x     Document Type: Article

References (34)

1. 1 Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and Immunobiologic approach to the spectrum of gluten sensitivity ('Celiac Sprue'). Gastroenterology 1992;102:330.
2. 2 Meeuwisse GW. Diagnostic criteria in coeliac disease. Acta Paediatr Scand 1970;59:461.
3. 3 Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of working group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65: 909.
4. 4 Peña A, Crusius J. Malignancy, autoimmune disease, survival and quality of life in coeliac disease. Pediatrika 1996;16:399.
5. 5 Holmes GKT, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989;30:333.
6. 6 Mäki M, Kallonen K, Láhdeaho ML, Visakorpi JK. Changing pattern of chidhood coeliac disease in Finland. Acta Paediatr Scand 1988;77:408.
7. 7 Dias JA, Walker-Smith JA. Down's Syndrome and coeliac disease. J Pediatr Gastroenterol Nutr 1990;10:41.
8. 8 Ventura A, Bouquet F, Santorelli C, Barbie E, Torre G, Tommasini G. Coeliac disease, folic acid deficiency and epilepsy with cerebral calcifications. Acta Paediatr Scand 1991;80:559.
9. 9 Ferguson A, Arranz E, O'Magibu S. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Gut 1993;34:150.
10. 10 Catassi C, Ratsch IM, Fabiani E, Rossini M, Bordicchia F, Candela F, Giorgi PL. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994;343:200.
11. 11 Calero P, Ribes-Koninckx C, Albiach V, Carles C, Ferrer J. IgA Antigliadin Antibodies as a screening method for non-overt celiac disease in children with insulin-dependent diabetes mellitus. J Paediatr Gastroenterol Nutr 1996;23:29.
12. 12 de Lecea A, Ribes-Koninckx C, Polanco I, Ferrer J. Serological screening (antigliadin and antiendomysium antibodies) for non-overt coeliac disease in children of short stature. Acta Paediatr Supplement 1996;412:54.
13. 13 Holmes GKT. Non-malignant complications of coeliac disease. Acta Paediatr Supplement 1996;412:54.
14. 14 Bürgin-Wolf A, Gaze H, Hadziselimovic F, Huber H, Lenteze MJ, Nüssle D. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch Dis Child 1991;66:941.
15. 15 Grodzinsky E, Jansson G, Skogh T, Stenhammanr L, Fälth-Magnusson K. Antiendomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine. Acta Paediatr 1995;84:294.
16. 16 Troncone R, Mayer M, Spagnuolo F, Maiuri L, Greco L. Endomysial antibodies as unreliable markers for slight transgresions in adolescents with celiac disease. J Pediatr Gastroenterol Nutr 1995;21:69.
17. 17 Ribes-Koninckx C, Giliams JP, Polanco I, Peña A. S Iga Antigliadin Antibodies Celiac Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 1984;3:676.
18. 18 Troncone R, Ferguson A. Anti-gliadin antibodies. J Pediatr Gastroenterol Nutr 1991;12:150.
19. 19 Corrao G, Corazza GR, Andreani ML, Torchio P, Valentini RA, Galatola G et al. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut 1994;35:771.
20. 20 Alfonso P, Soto C, Albar JP, Camafeita E, Escobar H, Suarez L et al. The implication of β structure motifs in the recognition of AGA. FEBS Lett 1998;427:36-40.
21. 21 Roche A, Colilla A, Luisa Ortiz M, Méndez E. Identification of the three major coeliac immunoreactive proteins and one α-amylaese inhibitor from oat endosperm. FEBS Lett 1992;310 (1):37-40.
22. 22 Rocher A, Soriano F, Molina E, Gonzalez-Limas G, Mendez E. Characterization of distinct α, and γ type gliadins and low molecular weight components from wheat endosperm as coeliac immunoeactive proteins. BBA 1995;1247:143-8.
23. 23 Rocher A, Calero M, Soriano F, Méndez E. Identification of the major secalins from rye endosperm as coeliac immunoreactive proteins. Biochimica Biophysica Acta 1996;1295:13-22.
24. 24 Chan KN, Phillips AD, Mirakian R, Walker-Smith JA. Endomysial Antibody screening in children. J Pediatr Gastroenterol Nutr 1994;18:316.
25. 25 Berger R, Schimdt G. Evaluation of six anti-gliadin antibody assays. J Immunol Methods 1996;191:77.
26. 26 Kennedy N, Gamble S, Abuzakouk M, Weir DD, Feighery C. A further study of wheat-free oats in the gluten-free diet of iris adults with coeliac disease. Eight International Symposium on Coeliac Disease, Naples. 1999:139 (Abstract).
27. 27 Vitoria JC, Arrieta A, Astigarraga I, Garcia-Masdevall D, Rodriguez-Soriano J. Use of serological markers as sreening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr 1994;19 (3):304.
28. 28 Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369.
29. 29 Dickey W, Mc Millan SA, Mc Crum EE, Evans AE. Association between serum levels of total IgA and IgA class endomysial and antigliadin antibodies: implications for coeliac disease screening. Eur J Gastroenterol Hepatol 1997;9 (6):559.
30. 30 Calabuig M, Ribes-Koninckx C. Prevalence of selective IgA deficiency in coeliac patients: Results of a multicenter study. Eight International Symposium on Coeliac Disease, Naples. 1999:231 (Abstract).
31. 31 Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;7:797.
32. 32 Dieterich W, Laag E, Schöpper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D. Autoantibodies to tissue Transglutaminase as Predictors of Celiac Disease. Gastroenterol 1998;115:1317-21.
33. 33 Sulkanen S, Halittunen T, Laurila K, Kolho KL, Korponay-Szabó IR, Sarniesto A, Savilahti E, Collin P. Mäki Markku Tissue Transglutaminase Autoantibody Enzyme-Linked Immunosorbent Assay Detecting Celiac Disease. Gastroenterol 1998;115:1322-8.
34. 34 Ribes-Koninck X, Calabuig M. Serological markers for coeliac disease: Results of a multicenter study in Spain. Eight International Symposium on Coeliac Disease, Naples. 1999;35(Abstract):196.